Titlebook: Cardiac Cell and Gene Transfer; Joseph M. Metzger (Director) Book 2003 Humana Press 2003

Adams

書目名稱Cardiac Cell and Gene Transfer影響因子(影響力)




書目名稱Cardiac Cell and Gene Transfer影響因子(影響力)學(xué)科排名




書目名稱Cardiac Cell and Gene Transfer網(wǎng)絡(luò)公開度




書目名稱Cardiac Cell and Gene Transfer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cardiac Cell and Gene Transfer被引頻次




書目名稱Cardiac Cell and Gene Transfer被引頻次學(xué)科排名




書目名稱Cardiac Cell and Gene Transfer年度引用




書目名稱Cardiac Cell and Gene Transfer年度引用學(xué)科排名




書目名稱Cardiac Cell and Gene Transfer讀者反饋




書目名稱Cardiac Cell and Gene Transfer讀者反饋學(xué)科排名

拉開這車床

Diaphragm

驚惶

Pander

Bashir Ahmad,Sotiris K. Ntouyases for the investigation of cardiac physiology. Methods include morselization or perfusion of the myocardium with various enzymatic solutions to disperse cells. Similar methods have been translated to larger species with variable yield and viability.

HOWL

Lentivirus Vector-Mediated Gene Transfer to Cardiomyocyteshe roles of individual genes in cardiovascular pathophysiology. Both efficient delivery and long-term expression of transduced genes is required before the full benefit of genetic manipulation strategies can be realized in the cardiovascular system. However, all the current methods of gene delivery have major limitations.

HOWL

Suppressor tRNAs in vivo can be regulated by the presence or absence of a suppressor tRNA. This technique has provided new approaches to cancer therapy (.) as well as to the study of visual system development in . (.).

CHASE

Antisense OligonucleotidesA (mRNA). By binding to the mRNA, the oligonucleotide prevents protein translation. This blockade may be mediated by RNAase-H degradation of the RNA-oligonucleotide complex. In addition to negative effects on protein translation, oligonucleotides may inhibit mRNA transcription through triple helix formation with complementary DNA regions (.–.).

痛苦一下

Mortal

Book 2003technologies offer the potential for new therapeutic strategies directed toward remediation of inherited and acquired heart diseases. Whether these recent basic science advances will ultimately translate to clinical efficacy for patients with heart disease is unknown and is important to ascertain. C